AP NEWS

Biological Autoimmune Therapeutics Market, 2022 - ResearchAndMarkets.com

November 20, 2018

DUBLIN--(BUSINESS WIRE)--Nov 20, 2018--The “Biological Autoimmune Therapeutics” report has been added to ResearchAndMarkets.com’s offering.

This report describes key factors in the trend toward user acceptance and designed-in usability. The influence of biosimilars on as-supplied packaging strategies is yet to be determined, but the need for product differentiation in an increasingly crowded market segment will make product packaging a key competitive factor.

The administration of therapeutic immune modulators is becoming an increasingly important healthcare treatment option for a growing number of diseases and indications having broad implications for patient health and well-being. But to fully exploit the value of this class of therapeutics in both human and commercial terms, developers must successfully navigate the inherent limitations of drug storage and administration, moving away from infusion and toward injection as a route of administration.

Antibody drug products indicated for chronic conditions such as autoimmunity are often re-formulated, re-packaged and re-labeled into injectable form and re-introduced two to three years post-market launch to address the growing economic pressure and patient desire to avoid the need for out-patient infusion in favor of self-injection.

Biological Autoimmune Therapeutics - What You Will Learn

What are the approved biological drugs indicated for autoimmune conditions, what is the as-supplied packaging, and who markets them? What are the major factors driving the growth of biological drugs for treating autoimmunity? What is the size of the market biological autoimmune therapeutics drugs today, who are the market share leaders, and what will it be in 2022? How important are drug developer-device manufacturer relationships and what are the key alliances in the industry? What are the essential design factors, technologies and market development issues for biological autoimmune drugs? What are the significant economic, technology, and regulatory factors affecting the market for immunotherapeutic drugs?

Key Topics Covered:

Executive Summary

Market Dynamics

Unmet Patient Needs Drug Development Patient Population Factors

The Autoimmune Patient

The Informed Patient Product Design & Patient Enablement Factors Ease of Use Patient Adherence Dosing Frequency

Product Landscape

Biosimilars Regional Market Product Strategies

As-Supplied Packaging and Administration

Device Selection - Stability and Material Issues Human Engineering/Ergonomics Pre- and Post-Marketing Device Evolution The Role of Prefilled Devices Prefilled Syringes Autoinjectors Special Feature Autoinjectors Pen Injectors Emerging Devices

The Product Ecosystem

Supplier Relationships Supplier Resources - Geographic Distribution Drug Supply Chain Activity

Product Analysis, Financial Performance & Forecasts

Development-stage Therapeutics

Autoimmune Therapeutics - Market Segment Analysis

Ankylosing Spondylitis Crohn’s Disease Adult Rheumatoid Arthritis Juvenile Idiopathic Arthritis Multiple Sclerosis Psoriatic Arthritis Ulcerative Colitis

Market Factors

Regulatory Factors United State/FDA Europe/EMA Clinical Trial Protocols & Endpoints Alliances and Partnerships

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/8v45lr/biological?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181120005312/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/20/2018 06:30 AM/DISC: 11/20/2018 06:30 AM

http://www.businesswire.com/news/home/20181120005312/en

AP RADIO
Update hourly